Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMDC.L Regulatory News (MDC)

  • There is currently no data for MDC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) -Mediclinic Intl plc Amendment

10 Nov 2017 16:35

RNS Number : 2303W
JPMorgan Securities Plc
10 November 2017
 

AMENDMENT

INCREASED EQUITY PURCHASES BY 1,977 TO 228,811

INCREASED EQUITY SALES BY 29,546 TO 364,215

REMOVED EQUITY SWAP PURCHASES OF 10,819

REMOVED EQUITY SWAP SALES OF 9,039

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-

SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mediclinic International plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker & Financial Advisor to Spire Healthcare Group plc

(d) Date dealing undertaken:

06 November 2017

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes

Spire Healthcare Group plc

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

 

Lowest price per unit paid/received

 

Ordinary Shares

 

Purchases

 

 

Sales

228,811 233,991

 

364,215 233,991

6.0103 GBP

110.7828 ZAR

 

6.0100 GBP

110.7100 ZAR

5.9200 GBP

110.6464 ZAR

 

5.9200 GBP

110.7100 ZAR

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

Ordinary Shares

Equity Swaps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,819

18,779

13,250

1,370

6,803

28,842

24,222

1,042

182,109

2,009

32,942

3,060

305

2,886

4,420

415

240

1,390

887

583

3,702

4,836

55,509

 

804

8,448

2,522

4,112

49,066

1,374

83,584

2,492

1,532

2,766

4,255

2,128

10,143

15,174

6,109

7,587

1,492

3,492

11,138

214

1,608

905

2,144

2,680

378

536

5,248

1,461

4,836

55,509

5.9262 GBP

5.9277 GBP

5.9423 GBP

5.9445 GBP

5.9479 GBP

5.9548 GBP

5.9553 GBP

5.9588 GBP

5.9599 GBP

5.9610 GBP

5.9634 GBP

5.9738 GBP

5.9768 GBP

5.9775 GBP

5.9785 GBP

5.9798 GBP

5.9826 GBP

5.9882 GBP

5.9923 GBP

5.9973 GBP

6.0096 GBP

110.4628 ZAR

110.6763 ZAR

 

5.9204 GBP

5.9455 GBP

5.9566 GBP

5.9567 GBP

5.9571 GBP

5.9602 GBP

5.9663 GBP

5.9666 GBP

5.9668 GBP

5.9671 GBP

5.9686 GBP

5.9747 GBP

5.9748 GBP

5.9769 GBP

5.9789 GBP

5.9800 GBP

5.9809 GBP

5.9885 GBP

5.9899 GBP

5.9900 GBP

5.9952 GBP

5.9956 GBP

5.9964 GBP

5.9972 GBP

5.9981 GBP

6.0002 GBP

6.0103 GBP

6.0104 GBP

110.4661 ZAR

110.6796 ZAR

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (GBP)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(GBP)

Ordinary Shares

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(GBP)

Ordinary Shares

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) (GBP)

 

 

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

10 November 2017

Contact name:

Evangelos Galiatsatos

Telephone number:

020 7742 6148

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERLLFVRLSLILID
Date   Source Headline
26th May 20234:36 pmRNSForm 8 (DD) - Mediclinic International plc
26th May 20232:45 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
26th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
26th May 202311:33 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International p
26th May 202311:28 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
26th May 202311:18 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
26th May 202310:45 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
26th May 20239:29 amRNSForm 8.5 (EPT/NON-RI)
26th May 20238:00 amRNSScheme of Arrangement becomes effective
26th May 20237:00 amRNSForm 8.3 - Mediclinic International plc
25th May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
25th May 20232:57 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:39 pmRNSForm 8.5 (EPT/RI) - Mediclinic International plc
25th May 20232:12 pmRNSForm 8.3 - Mediclinic International plc
25th May 20232:00 pmRNSDirector/PDMR Shareholding
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20231:37 pmRNSForm 8.5 (EPT/RI)- Replacement of Mediclinic
25th May 20231:00 pmRNSCourt Sanction of Scheme of Arrangement
25th May 202311:26 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International p
25th May 202311:25 amRNSForm 8.5 (EPT/RI) - Mediclinic
25th May 202310:48 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
25th May 202310:34 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
25th May 202310:34 amRNSForm 8.5 (EPT/RI)
24th May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
24th May 20232:17 pmRNSForm 8.3 - Mediclinic International PLC
24th May 202312:10 pmEQSForm 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
24th May 202312:00 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
24th May 202311:10 amRNSForm 8.5 (EPT/NON-RI)
24th May 202311:00 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International
24th May 202311:00 amRNSForm 8.5 (EPT/RI) - Mediclinic Amendment
24th May 202311:00 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
24th May 202310:32 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
24th May 202310:18 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
24th May 20239:30 amRNSConsideration Currency Exchange Rate
23rd May 20234:47 pmRNSForm 8.5 (EPT/RI)-Replacement of Mediclinic
23rd May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
23rd May 20233:19 pmRNSForm 8.3 - Mediclinic International plc
23rd May 20233:00 pmRNSForm 8.3 - Mediclinic International Plc
23rd May 202312:50 pmRNSForm 8 (DD) - Mediclinic International plc
23rd May 202312:19 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
23rd May 202311:39 amRNSForm 8.3 - Mediclinic International plc
23rd May 202311:21 amRNSForm 8.5 (EPT/RI) - Mediclinic
23rd May 202310:49 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic
23rd May 202310:15 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
23rd May 202310:13 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
22nd May 20236:01 pmRNSMediclinic International
22nd May 20233:42 pmRNSForm 8.3 - Mediclinic International Plc
22nd May 20233:34 pmRNSForm 8.3 - Mediclinic International Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.